New Mexico Educational Retirement Board Gilead Sciences, Inc. Transaction History

New Mexico Educational Retirement Board

  • $2.97 Billion
  • Q3 2024

A detailed history of New Mexico Educational Retirement Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New Mexico Educational Retirement Board holds 60,926 shares of GILD stock, worth $5.48 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
60,926
Previous 62,726 2.87%
Holding current value
$5.48 Million
Previous $4.3 Million 18.68%
% of portfolio
0.17%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$66.59 - $83.99 $119,862 - $151,182
-1,800 Reduced 2.87%
60,926 $5.11 Million
Q1 2024

Apr 23, 2024
SELL
$71.58 - $87.29 $730,116 - $890,358
-10,200 Reduced 13.99%
62,726 $4.6 Million
Q1 2024

Apr 17, 2024
BUY
$71.58 - $87.29 $572,640 - $698,320
8,000 Added 12.32%
72,926 $4.34 Million
Q3 2023

Nov 01, 2023
BUY
$73.94 - $80.67 $317,942 - $346,881
4,300 Added 7.09%
64,926 $4.87 Million
Q2 2023

Jul 17, 2023
BUY
$76.01 - $86.7 $197,626 - $225,420
2,600 Added 4.48%
60,626 $4.67 Million
Q1 2023

May 03, 2023
SELL
$77.31 - $88.08 $146,889 - $167,352
-1,900 Reduced 3.17%
58,026 $4.81 Million
Q4 2022

Feb 01, 2023
SELL
$62.32 - $89.47 $261,744 - $375,774
-4,200 Reduced 6.55%
59,926 $5.15 Million
Q3 2022

Oct 18, 2022
SELL
$59.54 - $68.01 $321,516 - $367,254
-5,400 Reduced 7.77%
64,126 $3.96 Million
Q2 2022

Jul 21, 2022
SELL
$57.72 - $65.01 $196,248 - $221,034
-3,400 Reduced 4.66%
69,526 $4.3 Million
Q1 2022

Apr 01, 2022
SELL
$57.92 - $72.58 $214,304 - $268,546
-3,700 Reduced 4.83%
72,926 $4.34 Million
Q4 2021

Jan 19, 2022
SELL
$64.88 - $73.64 $350,352 - $397,656
-5,400 Reduced 6.58%
76,626 $5.56 Million
Q3 2021

Oct 19, 2021
SELL
$67.69 - $73.03 $121,842 - $131,454
-1,800 Reduced 2.15%
82,026 $5.73 Million
Q2 2021

Jul 13, 2021
BUY
$63.47 - $69.35 $285,615 - $312,075
4,500 Added 5.67%
83,826 $5.77 Million
Q4 2020

Feb 02, 2021
SELL
$56.65 - $64.55 $62,315 - $71,005
-1,100 Reduced 1.37%
79,326 $4.62 Million
Q3 2020

Oct 28, 2020
SELL
$62.1 - $78.08 $1.1 Million - $1.38 Million
-17,650 Reduced 18.0%
80,426 $5.08 Million
Q3 2020

Oct 27, 2020
BUY
$62.1 - $78.08 $804,195 - $1.01 Million
12,950 Added 15.21%
98,076 $6.22 Million
Q2 2020

Aug 06, 2020
BUY
$72.34 - $84.0 $397,870 - $462,000
5,500 Added 6.91%
85,126 $6.55 Million
Q1 2020

Jun 11, 2020
SELL
$62.63 - $80.22 $1.16 Million - $1.48 Million
-18,450 Reduced 18.81%
79,626 $5.95 Million
Q3 2019

Nov 25, 2019
SELL
$62.51 - $69.0 $400,064 - $441,600
-6,400 Reduced 6.13%
98,076 $6.22 Million
Q2 2019

Aug 06, 2019
SELL
$61.87 - $69.38 $210,358 - $235,891
-3,400 Reduced 3.15%
104,476 $7.06 Million
Q1 2019

Apr 17, 2019
SELL
$62.53 - $70.05 $156,325 - $175,125
-2,500 Reduced 2.26%
107,876 $7.01 Million
Q4 2018

Jan 28, 2019
SELL
$60.54 - $79.0 $332,970 - $434,500
-5,500 Reduced 4.75%
110,376 $6.9 Million
Q3 2018

Nov 19, 2018
SELL
$71.28 - $78.92 $349,272 - $386,708
-4,900 Reduced 4.06%
115,876 $8.95 Million
Q2 2018

Aug 01, 2018
SELL
$64.88 - $75.68 $240,055 - $280,016
-3,700 Reduced 2.97%
120,776 $8.56 Million
Q1 2018

Apr 25, 2018
SELL
$72.84 - $88.8 $72,840 - $88,800
-1,000 Reduced 0.8%
124,476 $9.38 Million
Q4 2017

Feb 08, 2018
BUY
$71.15 - $83.52 $284,600 - $334,080
4,000 Added 3.29%
125,476 $8.99 Million
Q3 2017

Nov 21, 2017
BUY
$72.11 - $85.47 $8.76 Million - $10.4 Million
121,476
121,476 $9.84 Million

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email